Regulators back statins

The agency that oversees Britain’s medicines has published an endorsement of cholesterol-lowering statins, arguing that they save lives.

The intervention of the Medicines and Healthcare products Regulatory Agency comes after a controversy stoked by the British Medical Journal over their effectiveness.

The journal has withdrawn claims it published suggesting that statins had serious side-effects.

And it is under pressure to withdraw articles questioning the overall effectiveness of the drugs.

The MHRA has now set out its view of the drugs in its publication Drug Safety Update.

This says that major clinical trials have shown that statins save lives by reducing the risks of heart attacks, strokes and the need for heart surgery.

The report says the most commonly reported side-effect is mild muscle pain – and that most side-effects experienced by users are "mild."

Dr June Raine, from the MHRA, said: "People should continue to take their statins as prescribed. Large clinical trials have shown that statins can save lives by reducing the risk of heart attacks, strokes and the need for heart surgery.

"The MHRA continually reviews the information on the safety of statins. We will update the prescribing advice for statins in light of any substantial new evidence of safety concerns."

Drug Safety Update June 2014

, ,

Leave a Reply

Your email address will not be published. Required fields are marked *

Search

Categories

Monthly Posts

Our Clients

BSH
Practice Index